Related Experiment Video
Updated: Jun 29, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
Temporal effects of p-chloroamphetamine on catecholamine synthesis
p-chloroamphetamine (PCA) initially boosts norepinephrine (NE) and dopamine (DA) synthesis. However, this effect on NE reverses after 1.25 hours, suggesting complex regulatory mechanisms.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Neuronal catecholamine synthesis involves complex regulatory mechanisms.
- p-chloroamphetamine (PCA) is a psychoactive substance known to affect monoamine neurotransmitters.
Purpose of the Study:
- To investigate the acute effects of p-chloroamphetamine (PCA) on the synthesis of norepinephrine (NE) and dopamine (DA).
- To explore the biphasic effects of PCA on NE synthesis and its implications for regulatory mechanisms.
Main Methods:
- Administration of 5 mg/kg of p-chloroamphetamine (PCA) to subjects.
- Measurement of the conversion index for norepinephrine (NE) and dopamine (DA) at 0.25 h and 1.25 h post-administration.
Main Results:
- Within 0.25 h, PCA significantly increased the conversion index of both NE and DA.
- At 1.25 h, the effect on DA synthesis was less pronounced, while the effect on NE synthesis was reversed, showing a decrease in the conversion index.
- A biphasic effect of PCA on NE synthesis was observed.
Conclusions:
- PCA exhibits a time-dependent biphasic effect on norepinephrine (NE) synthesis.
- These findings suggest the involvement of opposing regulatory mechanisms controlling neuronal catecholamine synthesis.
- The differential effects on NE and DA highlight the complexity of neurotransmitter regulation by PCA.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis